# Ayble Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ayble-health

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.ayblehealth.com
- Total disclosed funding: $21M
- Latest round: Series A (Sep 16, 2026)
- Investors on record: 7

## About

Based in Massachusetts, US, and founded in 2020, Ayble Health, Inc. operates as a healthcare technology company that provides a digital solution for patients with gastrointestinal disorders. The company was founded by Sam Jactel (CEO). In September 2026, Ayble Health, Inc. raised USD 16 million in series A funding led by Neon, with participation from Unum Ventures, Upfront, M13, Cleveland Clinic Ventures, DigiTx Partners, and Accomplice.

Ayble Health, Inc. runs a digital platform for gastroenterology care, with the goal of assisting individuals in tracking their daily food intake. Furthermore, users can access health assessments, communicate with dietitians, and track valuable health information through their platform, all with the goal of supporting optimal gut health maintenance.

The company generates revenue through subscription based access to its virtual digestive health clinic, which combines a multidisciplinary care team with AI powered digestive insights and personalized patient support.

The company plans to use the September 2026 funding to improve AI-driven digestive care and expand into autoimmune health.

## Funding rounds

- Series A, Sep 16, 2026, $16M — Upfront, Accomplice, M13, DigiTx Partners, Cleveland Clinic Ventures, Unum Ventures, Neon
- Seed, Nov 16, 2022, $4.6M — Upfront, M13

## Investors

- Upfront (https://capitalatlas.ai/funds/upfront) — Seed, Series A
- M13 (https://capitalatlas.ai/funds/m13) — Seed, Series A
- Accomplice (https://capitalatlas.ai/funds/accomplice) — Series A
- DigiTx Partners (https://capitalatlas.ai/funds/digitx-partners) — Series A
- Cleveland Clinic Ventures (https://capitalatlas.ai/funds/cleveland-clinic-ventures) — Series A
- Unum Ventures (https://capitalatlas.ai/funds/unum-ventures) — Series A
- Neon — Series A